The Cooper Cos., Inc. (COO)
54.74
-1.68
(-2.99%)
USD |
NASDAQ |
Oct 07, 16:00
54.65
-0.10
(-0.17%)
After-Hours: 20:00
Cooper Cos. Enterprise Value : 13.12B for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 13.12B |
| October 05, 2026 | 13.18B |
| October 02, 2026 | 13.21B |
| October 01, 2026 | 13.30B |
| September 30, 2026 | 13.14B |
| September 29, 2026 | 13.15B |
| September 28, 2026 | 13.14B |
| September 25, 2026 | 12.92B |
| September 24, 2026 | 12.92B |
| September 23, 2026 | 13.05B |
| September 22, 2026 | 12.90B |
| September 21, 2026 | 12.68B |
| September 18, 2026 | 12.90B |
| September 17, 2026 | 12.61B |
| September 16, 2026 | 12.77B |
| September 15, 2026 | 12.52B |
| September 14, 2026 | 12.70B |
| September 11, 2026 | 12.64B |
| September 10, 2026 | 12.69B |
| September 09, 2026 | 14.46B |
| September 08, 2026 | 15.26B |
| September 04, 2026 | 15.62B |
| September 03, 2026 | 15.82B |
| September 02, 2026 | 15.65B |
| September 01, 2026 | 15.56B |
| Date | Value |
|---|---|
| August 31, 2026 | 15.71B |
| August 28, 2026 | 15.92B |
| August 27, 2026 | 15.88B |
| August 26, 2026 | 16.21B |
| August 25, 2026 | 16.27B |
| August 24, 2026 | 16.80B |
| August 21, 2026 | 16.88B |
| August 20, 2026 | 16.87B |
| August 19, 2026 | 16.98B |
| August 18, 2026 | 16.79B |
| August 17, 2026 | 16.67B |
| August 14, 2026 | 16.87B |
| August 13, 2026 | 16.95B |
| August 12, 2026 | 16.98B |
| August 11, 2026 | 16.99B |
| August 10, 2026 | 16.90B |
| August 07, 2026 | 16.50B |
| August 06, 2026 | 16.33B |
| August 05, 2026 | 16.62B |
| August 04, 2026 | 16.59B |
| August 03, 2026 | 16.50B |
| July 31, 2026 | 16.14B |
| July 30, 2026 | 16.48B |
| July 29, 2026 | 16.56B |
| July 28, 2026 | 16.37B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Globus Medical, Inc. | 9.778B |
| Stryker Corp. | 118.68B |
| Boston Scientific Corp. | 73.25B |
| West Pharmaceutical Services, Inc. | 26.11B |
| IDEXX Laboratories, Inc. | 41.55B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 432.80M |
| Revenue (Quarterly) | 1.066B |
| Total Expenses (Quarterly) | 633.40M |
| EPS Diluted (Quarterly) | 2.238 |
| Gross Profit Margin (Quarterly) | 62.36% |
| Profit Margin (Quarterly) | 40.59% |
| Earnings Yield | 5.35% |
| Operating Earnings Yield | 7.61% |
| Normalized Earnings Yield | 7.136 |